← brief for 2026-09-19 · Slowing decline

Finerenone attenuates myocardial fibrosis in myocardial infarction complicated by chronic kidney disease: an integrated study combining network pharmacology, molecular simulations, and in vivo experiments.

Article D Peer reviewed Preclinical

Key takeaways

This study used computer models and animal tests to look at a drug called finerenone. It examined how the drug affects heart scarring in people with kidney disease. The results are from animals and simulations, not people yet.

Who did this work

Xiang Y · Chen J · Ruan X · Gao X · Jing L · Zhang W · Xu J · Liu Y

Source

Article · PubMed, the drug frontier · 2026 Sep 19
https://pubmed.ncbi.nlm.nih.gov/42762910/